Non-Regulatory
November 10, 2020
Non-Regulatory
May 10, 2017
Affibody To Initiate Phase II Psoriasis Trials For Lead Candidate ABY-035
Non-Regulatory
April 30, 2013
First Patient Included in PET Imaging Study of HER2 Expression in Metastatic Breast Cancer